Borrelia burgdorferi is a bacterium that causes Lyme disease and encodes many conserved proteins with unknown structures and functions, some of which play essential roles in microbial infectivity . BB_0268 was initially annotated as a homolog of Hfq, an RNA-binding protein, but has been recharacterized as FlgV, a structural flagellar component that modulates flagellar assembly .
BB_0268, now known as FlgV, is a broadly conserved gene found in the flagellar superoperon alongside σ28 in many Spirochaetes, Firmicutes, and other phyla, with distant homologs in Epsilonproteobacteria . FlgV is localized within flagellar motors and impacts the number and length of flagellar filaments . Borrelia burgdorferi lacking flgV construct fewer and shorter flagellar filaments and are defective in cell division and motility .
During the enzootic cycle, B. burgdorferi lacking flgV can survive and replicate in Ixodes ticks, but they are attenuated for dissemination and infection in mice . This suggests that FlgV plays a crucial role in the late-stage flagellar assembly and is important for B. burgdorferi's dissemination during mouse infection .
KEGG: bbu:BB_0268
STRING: 224326.BB_0268
Immunolocalization studies have demonstrated that FlgV (BB_0268) is primarily localized within the flagellar motors of Borrelia burgdorferi . This subcellular localization aligns with its functional role in flagellar assembly, providing strong evidence against previous hypotheses that it functioned as an RNA-binding protein in the cytoplasm.
Northern analysis reveals that BB_0268 is expressed as part of multiple transcripts ranging in length from approximately 500 to 6,000 nucleotides across different growth phases . These transcripts include neighboring genes such as fapA (BB_0267), flhG (BB_0269), and flhB (BB_0272), indicating that BB_0268 is co-transcribed as part of larger operons involving other flagellar components .
FlgV functions as a structural flagellar component that modulates flagellar assembly in Borrelia burgdorferi. When the protein is absent, bacteria construct fewer and shorter flagellar filaments, resulting in defective cell division and reduced motility . This indicates that FlgV plays a crucial role in the proper assembly and function of the flagellar apparatus.
Researchers can generate FlgV-deficient Borrelia burgdorferi strains by replacing the BB_0268 ORF with an antibiotic resistance cassette (such as the streptomycin resistance gene aadA) . The resulting mutant strains can then be analyzed using electron microscopy to quantify flagellar number and measure flagellar filament length. Comparative analysis between wild-type and knockout strains enables precise determination of FlgV's contribution to flagellar structure.
Co-immunoprecipitation (co-IP) experiments using C-terminal 3XFLAG tagged derivatives of BB_0268 expressed from the endogenous chromosomal location provide an effective approach . This method allows researchers to identify proteins that physically interact with FlgV. The experimental protocol should include appropriate controls (such as untagged wild-type strains) and verification of tagged protein expression through immunoblot analysis of cell lysate, supernatant, and elution samples.
FlgV is broadly conserved in the flagellar superoperon alongside σ28 in many bacterial phyla, including Spirochaetes and Firmicutes, with distant homologs also present in Epsilonproteobacteria . This widespread conservation suggests that FlgV performs a fundamentally important role in flagellar structure or function across diverse bacterial lineages.
Researchers can employ sequence similarity searches using tools like BLAST against comprehensive bacterial genome databases. Additionally, structural prediction algorithms can help identify functionally similar proteins despite low sequence conservation. When analyzing potential homologs, researchers should consider genomic context, particularly the proximity to other flagellar genes, as FlgV is typically located within flagellar operons .
B. burgdorferi strains lacking FlgV can survive and replicate within Ixodes ticks but show significant attenuation in their ability to disseminate and establish infection in mice . This indicates that while FlgV is not essential for survival in the tick vector, it plays a critical role in mammalian host infection, particularly in the dissemination phase where bacterial motility is likely crucial.
The most comprehensive approach involves the complete enzootic cycle model, incorporating both the tick vector (Ixodes sp.) and mammalian host (typically mice) . This model allows researchers to assess the impact of FlgV at each stage of the Borrelia life cycle. In vitro motility assays complement these in vivo approaches by providing quantitative measurements of how FlgV affects bacterial movement in controlled conditions.
For optimal expression and purification of recombinant BB_0268, researchers should consider the following methodological approach:
Express the protein in an Escherichia coli system using optimized codons for enhanced expression .
Include affinity tags (such as His-tag or FLAG-tag) to facilitate purification.
Employ a purification protocol involving metal affinity chromatography followed by size exclusion chromatography to ensure high purity.
Verify protein identity and integrity using mass spectrometry and Western blotting.
To resolve contradictions between previous studies suggesting RNA-binding functions and newer evidence indicating a structural role, researchers should:
Conduct rigorous electrophoretic mobility shift assays with appropriate controls and physiologically relevant protein:RNA ratios (closer to ~15:1 molecules rather than the ~823:1 used in earlier studies) .
Perform comparative binding studies with known RNA-binding proteins like E. coli Hfq.
Use northern analysis to assess RNA profiles in BB_0268 knockout strains vs. wild-type.
Employ RNA immunoprecipitation followed by sequencing (RIP-seq) to identify any RNAs that might associate with BB_0268 in vivo.
Advanced motility assessment requires a multi-faceted approach:
Tracking-based video microscopy to measure swimming speed, directional changes, and run-tumble patterns.
Swarm plate assays to assess population-level motility on semi-solid media.
Microfluidic devices to evaluate motility under controlled flow conditions and chemical gradients.
High-resolution electron microscopy (cryo-EM) to visualize structural differences in flagellar assemblies.
Given the extensive research on various Borrelia burgdorferi proteins for serodiagnostic applications, it's valid to consider FlgV's potential utility. Based on studies of other Borrelia proteins, potential serodiagnostic applications would require:
Production of recombinant FlgV from multiple Borrelia genospecies (B. afzelii, B. burgdorferi sensu stricto, and B. garinii) to account for strain variation .
Assessment of reactivity with both IgG and IgM antibodies in patient sera using Western blot and ELISA techniques .
Determination of sensitivity and specificity values compared to established serodiagnostic antigens.
The table below shows how FlgV would need to be evaluated in comparison to other Borrelia proteins currently being investigated for serodiagnostic potential:
| Recombinant Protein | Sensitivity (n = 25) | Specificity (n = 25) | PPV | NPV | Statistical Significance (p < 0.05) |
|---|---|---|---|---|---|
| FlgV (hypothetical) | Not yet determined | Not yet determined | - | - | - |
| BB0108 BA | 48% (12/25) | 92% (2/25) | 86% | 64% | Yes (p = 0.0036) |
| BB0108 BB | 40% (10/25) | 96% (1/25) | 91% | 62% | Yes (p = 0.0046) |
| BB0108 BG | 44% (11/25) | 88% (3/25) | 79% | 61% | Yes (p = 0.0255) |
| BB0323 BA | 44% (11/25) | 88% (3/25) | 79% | 61% | Yes (p = 0.0255) |
| BB0323 BB | 36% (9/25) | 92% (2/25) | 82% | 59% | Yes (p = 0.0374) |
| BB0323 BG | 44% (11/25) | 92% (2/25) | 85% | 62% | Yes (p = 0.0083) |
Note: FlgV values are hypothetical as this specific analysis has not been reported in the literature; other values represent actual data for comparison proteins.
When designing experiments to study FlgV function, researchers should implement the following controls:
Wild-type (WT) Borrelia burgdorferi strains as positive controls .
FlgV genetic complementation strains to verify that observed phenotypes are specifically due to FlgV absence rather than polar effects or secondary mutations .
Growth curve measurements to ensure that any observed phenotypes are not due to general growth defects .
Strains with mutations in other flagellar genes to distinguish FlgV-specific effects from general flagellar defects.
Researchers should follow systematic experimental design principles, including:
Clearly defining the independent variable (FlgV presence/absence or modification) and dependent variables (flagellar structure, motility, infection capability)3.
Controlling for confounding variables through appropriate experimental controls and randomization3 .
Determining appropriate sample sizes through power analysis to ensure statistical validity .
Using varied methodological approaches to test the same hypothesis, providing stronger evidence when consistent results are obtained across different methods .
Future research should focus on:
Determining the precise molecular mechanism by which FlgV influences flagellar assembly.
Identifying the protein interactions of FlgV within the flagellar motor complex.
Investigating the potential of FlgV as a therapeutic target, given its importance for bacterial dissemination during infection.
Exploring the evolutionary relationship between FlgV and other flagellar proteins across diverse bacterial species.
Advanced structural biology techniques like cryo-electron microscopy, X-ray crystallography, and nuclear magnetic resonance spectroscopy could provide crucial insights into:
The three-dimensional structure of FlgV at atomic resolution.
The structural basis for FlgV's interaction with other flagellar components.
Potential conformational changes in FlgV during flagellar assembly and function.
Structure-based design of inhibitors that could disrupt FlgV function as potential therapeutics.